Curt LaBelle's most recent trade in Revelation Biosciences Inc was a trade of 6,356 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revelation Biosciences Inc | Curt H. LaBelle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 6,356 | 6,356 | - | - | Stock Option (Right to Buy) | |
| Hyperion DeFi Inc. | Curt H. LaBelle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 9,653 | 9,653 | - | - | Stock Option (right to buy) | |
| Hyperion DeFi Inc. | Curt H. LaBelle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 6,963 | 42,236 (0%) | 0% | 0 | Common Stock, par value $.0001 | |
| Hyperion DeFi Inc. | Curt LaBelle | Director | Other type of transaction at price $ 0.00 per share. | 20 Nov 2020 | 453,333 | 0 (0%) | 2% | 0 | Common Stock, par value $.0001 | |
| Hyperion DeFi Inc. | Curt LaBelle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2020 | 9,820 | 9,820 | - | - | Stock Option (right to buy) | |
| Hyperion DeFi Inc. | Curt LaBelle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2020 | 7,288 | 35,273 (0%) | 0% | 0 | Common Stock, par value $.0001 |